Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.

Schier CJ, Marks WD, Paris JJ, Barbour AJ, McLane VD, Maragos WF, McQuiston AR, Knapp PE, Hauser KF.

J Neurosci. 2017 Jun 7;37(23):5758-5769. doi: 10.1523/JNEUROSCI.0622-17.2017. Epub 2017 May 4.

PMID:
28473642
2.

Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?

Johnson KA, Lovinger DM.

Front Cell Neurosci. 2016 Nov 11;10:264. eCollection 2016. Review.

3.

Effects of D1 receptor knockout on fear and reward learning.

Abraham AD, Neve KA, Lattal KM.

Neurobiol Learn Mem. 2016 Sep;133:265-73. doi: 10.1016/j.nlm.2016.07.010. Epub 2016 Jul 14.

4.

Effect of olfactory manganese exposure on anxiety-related behavior in a mouse model of iron overload hemochromatosis.

Ye Q, Kim J.

Environ Toxicol Pharmacol. 2015 Jul;40(1):333-41. doi: 10.1016/j.etap.2015.06.016. Epub 2015 Jun 23.

5.

Post-transcriptional regulation of dopamine D1 receptor expression in caudate-putamen of cocaine-sensitized mice.

Tobón KE, Catuzzi JE, Cote SR, Sonaike A, Kuzhikandathil EV.

Eur J Neurosci. 2015 Jul;42(2):1849-57. doi: 10.1111/ejn.12933. Epub 2015 May 18.

6.

Cocaine-induced behavioral sensitization in mice: effects of microinjection of dopamine d2 receptor antagonist into the nucleus accumbens.

Jung ES, Lee HJ, Sim HR, Baik JH.

Exp Neurobiol. 2013 Sep;22(3):224-31. doi: 10.5607/en.2013.22.3.224. Epub 2013 Sep 30.

7.

Methamphetamine increases locomotion and dopamine transporter activity in dopamine d5 receptor-deficient mice.

Hayashizaki S, Hirai S, Ito Y, Honda Y, Arime Y, Sora I, Okado H, Kodama T, Takada M.

PLoS One. 2013 Oct 14;8(10):e75975. doi: 10.1371/journal.pone.0075975. eCollection 2013.

8.

Dopamine signaling in reward-related behaviors.

Baik JH.

Front Neural Circuits. 2013 Oct 11;7:152. doi: 10.3389/fncir.2013.00152. eCollection 2013. Review.

9.

Convergent effects of mouse Pet-1 deletion and human PET-1 variation on amygdala fear and threat processing.

Wellman CL, Camp M, Jones VM, MacPherson KP, Ihne J, Fitzgerald P, Maroun M, Drabant E, Bogdan R, Hariri AR, Holmes A.

Exp Neurol. 2013 Dec;250:260-9. doi: 10.1016/j.expneurol.2013.09.025. Epub 2013 Oct 4. Erratum in: Exp Neurol. 2014 Feb;252:104.

10.

Preadolescent drd1-EGFP mice exhibit cocaine-induced behavioral sensitization.

Tobón KE, Kuzhikandathil EV.

Neurosci Lett. 2014 Jan 13;558:20-5. doi: 10.1016/j.neulet.2013.09.051. Epub 2013 Oct 1.

11.

L-isocorypalmine reduces behavioral sensitization and rewarding effects of cocaine in mice by acting on dopamine receptors.

Xu W, Wang Y, Ma Z, Chiu YT, Huang P, Rasakham K, Unterwald E, Lee DY, Liu-Chen LY.

Drug Alcohol Depend. 2013 Dec 1;133(2):693-703. doi: 10.1016/j.drugalcdep.2013.08.021. Epub 2013 Sep 2.

12.

Genetic reconstruction of dopamine D1 receptor signaling in the nucleus accumbens facilitates natural and drug reward responses.

Gore BB, Zweifel LS.

J Neurosci. 2013 May 15;33(20):8640-9. doi: 10.1523/JNEUROSCI.5532-12.2013.

13.

A role for kalirin in the response of rat medium spiny neurons to cocaine.

Ma XM, Huang JP, Xin X, Yan Y, Mains RE, Eipper BA.

Mol Pharmacol. 2012 Oct;82(4):738-45. Epub 2012 Jul 24.

14.

Differential regulation of motor control and response to dopaminergic drugs by D1R and D2R neurons in distinct dorsal striatum subregions.

Durieux PF, Schiffmann SN, de Kerchove d'Exaerde A.

EMBO J. 2012 Feb 1;31(3):640-53. doi: 10.1038/emboj.2011.400. Epub 2011 Nov 8.

15.

Psychomotor stimulant effects of cocaine in rats and 15 mouse strains.

Thomsen M, Caine SB.

Exp Clin Psychopharmacol. 2011 Oct;19(5):321-41. doi: 10.1037/a0024798.

16.

A novel role for PSD-95 in mediating ethanol intoxication, drinking and place preference.

Camp MC, Feyder M, Ihne J, Palachick B, Hurd B, Karlsson RM, Noronha B, Chen YC, Coba MP, Grant SG, Holmes A.

Addict Biol. 2011 Jul;16(3):428-39. doi: 10.1111/j.1369-1600.2010.00282.x. Epub 2011 Feb 11.

17.

Lack of renal dopamine D5 receptors promotes hypertension.

Asico L, Zhang X, Jiang J, Cabrera D, Escano CS, Sibley DR, Wang X, Yang Y, Mannon R, Jones JE, Armando I, Jose PA.

J Am Soc Nephrol. 2011 Jan;22(1):82-9. doi: 10.1681/ASN.2010050533. Epub 2010 Nov 4.

18.

Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

van den Buuse M.

Schizophr Bull. 2010 Mar;36(2):246-70. doi: 10.1093/schbul/sbp132. Epub 2009 Nov 9. Review.

19.

Restoration of amphetamine-induced locomotor sensitization in dopamine D1 receptor-deficient mice.

El-Ghundi MB, Fan T, Karasinska JM, Yeung J, Zhou M, O'Dowd BF, George SR.

Psychopharmacology (Berl). 2010 Jan;207(4):599-618. doi: 10.1007/s00213-009-1690-5. Epub 2009 Oct 15.

20.

Mechanisms of locomotor sensitization to drugs of abuse in a two-injection protocol.

Valjent E, Bertran-Gonzalez J, Aubier B, Greengard P, Hervé D, Girault JA.

Neuropsychopharmacology. 2010 Jan;35(2):401-15. doi: 10.1038/npp.2009.143.

Supplemental Content

Support Center